ANDROGEN, ESTROGEN, AND PROGESTERONE RECEPTORS IN NORMAL AND AGING PROSTATES

被引:33
作者
SRINIVASAN, G
CAMPBELL, E
BASHIRELAHI, N
机构
[1] UNIV MARYLAND,SCH DENT,DEPT BIOCHEM,BALTIMORE,MD 21201
[2] UNIV MARYLAND,SCH MED,DEPT SURG,DIV UROL,BALTIMORE,MD 21201
[3] UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77551
关键词
TESTICULAR HORMONES; BPH; CANCER;
D O I
10.1002/jemt.1070300405
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Testicular hormones regulate the growth and development of the prostate. The presence of androgen receptors in prostatic tissue and their importance in the normal development of the prostate has been established. Age-related changes in the hormonal milieu, and perhaps steroid hormone receptor profile, could set in motion pathological changes leading to the onset of benign prostatic hyperplasia (BPH) or prostate cancer which primarily affect older men. The accumulation of dihydrotestosterone with age, the reawakening of the inductive potential of the prostatic stroma, the altered rate of apoptosis with age, and the age-related changes in the ratio of testosterone:estrogen have all been implicated in the etiology of BPH. In addition to androgen receptors, several studies have documented the presence of estrogen and progesterone receptors in BPH and prostate cancer. So far, most studies have focussed on the correlation between the presence/absence of steroid hormone receptors and response to hormonal therapy. The molecular mechanisms by which these steroid hormone receptors regulate the onset or progression of BPH and prostate cancer are not yet clear. The chronological changes in the levels and distribution of steroid hormone receptors in normal prostatic tissue and the effect of such changes on the synthesis of growth factors, growth factor receptors, and oncogenes should be investigated. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:293 / 304
页数:12
相关论文
共 86 条
[31]   DEVELOPMENT OF A MODEL FOR THE INDUCTION OF ESTROGEN-RELATED PROSTATIC HYPERPLASIA IN THE DOG AND ITS RESPONSE TO THE AROMATASE INHIBITOR 4-HYDROXY-4-ANDROSTENE-3,17-DIONE - PRELIMINARY-RESULTS [J].
HABENICHT, UF ;
SCHWARZ, K ;
SCHWEIKERT, HU ;
NEUMANN, F ;
ELETREBY, MF .
PROSTATE, 1986, 8 (02) :181-194
[32]   STEROID RECEPTORS IN HUMAN PROSTATE .1. ESTRADIOL - 17BETA BINDING IN BENIGN PROSTATIC HYPERTROPHY [J].
HAWKINS, EF ;
NIJS, M ;
BRASSINNE, C ;
TAGNON, HJ .
STEROIDS, 1975, 26 (04) :458-469
[33]  
HELPAP B, 1992, BENIGN PROSTATIC DIS, P84
[34]   REGULATION OF 1,25(OH)2VITAMIN-D3 RECEPTOR CONTENT IN CULTURED LLC-PK1 KIDNEY-CELLS LIMITS HORMONAL RESPONSIVENESS [J].
HIRST, M ;
FELDMAN, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (01) :121-127
[35]  
HO SM, 1993, CANCER RES, V53, P528
[36]   PROSTATIC CYTOSOL BINDING OF 5-ALPHA-ANDROSTANE-3-BETA,17-BETA-DIOL AND ESTRADIOL-17-BETA [J].
HO, SM ;
OFNER, P .
STEROIDS, 1986, 47 (01) :21-34
[37]   The effect of castration on benign hypertrophy of the prostate in man [J].
Huggins, C ;
Stevens, RA .
JOURNAL OF UROLOGY, 1940, 43 (05) :705-714
[38]  
Huggins C, 1941, CANCER RES, V1, P293
[39]   ANTAGONISTIC EFFECT OF ANDROGEN ON PROSTATIC CELL-DEATH [J].
ISAACS, JT .
PROSTATE, 1984, 5 (05) :545-557
[40]   FORMATION OF 5-ALPHA-ANDROSTANE-3-ALPHA,17-BETA-DIOL BY NORMAL AND HYPERTROPHIC HUMAN PROSTATE [J].
JACOBI, GH ;
WILSON, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (01) :107-115